ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2020

Analysis of C. difficile infection-related outcomes in European participants in the bezlotoxumab MODIFY I and II trials.

Emilio Bouza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.